Last updated: July 05, 2026

Application No. 18/884,577

LIPID COMPOSITION

Non-Final OA

Filed

Sep 13, 2024

Priority

Mar 15, 2022 — JP 2022-039874 +1 more

Examiner

ARNOLD, ERNST V

Art Unit

1613

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Fujifilm Corporation

OA Round

1 (Non-Final)

Interview Optional

— +12.9% interview lift. Interview lift (+12.9%) is below the 15.0% threshold. A written response is recommended.

Based on 1375 resolved cases, 2023–2026

Examiner Intelligence

ARNOLD, ERNST V View full profile →

Grants 48% of resolved cases

Career Allowance Rate

660 granted / 1375 resolved

-12.0% vs TC avg

Moderate +13% lift

Without

With

+12.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

77 currently pending

Career history

1444

Total Applications

across all art units

Statute-Specific Performance

§101

0.6%

-39.4% vs TC avg

§103

57.3%

+17.3% vs TC avg

§102

5.3%

-34.7% vs TC avg

§112

2.8%

-37.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1375 resolved cases

Prosecution Timeline

Sep 13, 2024

Application Filed

Apr 03, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/421,265

Patent 12661477

NITRIC OXIDE THERAPIES

2y 5m to grant Granted Jun 23, 2026

18/120,762

Patent 12642871

Lyophilized Formulations of AAV Drug Products

3y 2m to grant Granted Jun 02, 2026

18/658,338

Patent 12629388

INTRADIALYTIC USE OF SODIUM NITRITE

2y 0m to grant Granted May 19, 2026

18/630,735

Patent 12616775

METHOD FOR MANUFACTURING BONE-REGENERATION MATERIAL COMPRISING BIODEGRADABLE FIBERS BY USING ELECTROSPINNING METHOD

2y 0m to grant Granted May 05, 2026

18/267,783

Patent 12611385

USE OF TWO-DIMENSIONAL NANOMATERIAL IN INHIBITION OF CORONAVIRUS

2y 10m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

48%

Grant Probability

61%

With Interview (+12.9%)

3y 2m (~1y 4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1375 resolved cases by this examiner. Grant probability derived from career allowance rate.